Crescent Capital Ownership

CCAP Stock  USD 17.63  0.11  0.62%   
Crescent Capital holds a total of 37.06 Million outstanding shares. 30% of Crescent Capital BDC outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
 
Shares in Circulation  
First Issued
2019-06-30
Previous Quarter
37 M
Current Value
37 M
Avarage Shares Outstanding
30.5 M
Quarterly Volatility
5.7 M
 
Covid
As of 03/22/2025, Dividend Paid And Capex Coverage Ratio is likely to grow to 0.82, though Dividends Paid is likely to grow to (71.5 M). As of 03/22/2025, Net Income Applicable To Common Shares is likely to grow to about 28.9 M, while Common Stock Shares Outstanding is likely to drop slightly above 32.1 M.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Crescent Capital BDC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Crescent Stock Ownership Analysis

About 12.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.88. Some equities with similar Price to Book (P/B) outperform the market in the long run. Crescent Capital BDC has Price/Earnings To Growth (PEG) ratio of 0.89. The entity last dividend was issued on the 31st of March 2025. Crescent Capital BDC, Inc. is as a business development company private equity buyouts and loan fund. Crescent Capital operates under Asset Management classification in the United States and is traded on NASDAQ Exchange. For more info on Crescent Capital BDC please contact Jason Breaux at 310 235 5900 or go to https://www.crescentbdc.com.
Besides selling stocks to institutional investors, Crescent Capital also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Crescent Capital's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Crescent Capital's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Crescent Capital Quarterly Liabilities And Stockholders Equity

1.66 Billion

Crescent Capital Insider Trades History

About 12.0% of Crescent Capital BDC are currently held by insiders. Unlike Crescent Capital's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Crescent Capital's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Crescent Capital's insider trades
 
Yuan Drop
 
Covid

Crescent Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Crescent Capital is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Crescent Capital BDC backward and forwards among themselves. Crescent Capital's institutional investor refers to the entity that pools money to purchase Crescent Capital's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Denali Advisors Llc2024-12-31
183.8 K
Kovitz Investment Group Partners, Llc2024-12-31
177.3 K
Blackrock Inc2024-12-31
167.6 K
Hightower Advisors, Llc2024-12-31
136.7 K
Morgan Stanley - Brokerage Accounts2024-12-31
119.1 K
Rockefeller Capital Management L.p.2024-12-31
118.6 K
Ubs Group Ag2024-12-31
117 K
Barclays Plc2024-12-31
116.1 K
Skandinaviska Enskilda Banken Ab2024-12-31
109.3 K
Texas County & District Retirement System2024-12-31
M
Fidelity National Title Group, Inc.2024-12-31
4.2 M
Note, although Crescent Capital's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Crescent Capital BDC Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Crescent Capital insiders, such as employees or executives, is commonly permitted as long as it does not rely on Crescent Capital's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Crescent Capital insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Crescent Capital Outstanding Bonds

Crescent Capital issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Crescent Capital BDC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Crescent bonds can be classified according to their maturity, which is the date when Crescent Capital BDC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Crescent Capital Corporate Filings

28th of February 2025
Other Reports
ViewVerify
10K
19th of February 2025
Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance
ViewVerify
14th of February 2025
Other Reports
ViewVerify
F5
13th of February 2025
The annual filing required by the Securities and Exchange Commission (SEC) from company insiders or beneficial owners
ViewVerify

Pair Trading with Crescent Capital

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Crescent Capital position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crescent Capital will appreciate offsetting losses from the drop in the long position's value.

Moving together with Crescent Stock

  0.95MC MoelisPairCorr
  0.82MS Morgan StanleyPairCorr

Moving against Crescent Stock

  0.77CB ChubbPairCorr
  0.51TWO Two Harbors InvestmentsPairCorr
  0.5BBUC Brookfield Business CorpPairCorr
  0.45FORLU Four Leaf AcquisitionPairCorr
  0.42MFA MFA FinancialPairCorr
The ability to find closely correlated positions to Crescent Capital could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Crescent Capital when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Crescent Capital - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Crescent Capital BDC to buy it.
The correlation of Crescent Capital is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Crescent Capital moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Crescent Capital BDC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Crescent Capital can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Crescent Stock Analysis

When running Crescent Capital's price analysis, check to measure Crescent Capital's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Crescent Capital is operating at the current time. Most of Crescent Capital's value examination focuses on studying past and present price action to predict the probability of Crescent Capital's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Crescent Capital's price. Additionally, you may evaluate how the addition of Crescent Capital to your portfolios can decrease your overall portfolio volatility.